ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q3SCImago #12,218Hybrid

Advances in Experimental Medicine and Biology

Abbreviation (ISO):ADV EXP MED BIOL
•
Identifier (ISSN):0065-2598(Print)/2214-8019(Online)
•
Publisher:Springer New York
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend (2020–2025)

Clarivate IF trend for Advances in Experimental Medicine and Biology

WoS Q1
02351.7620202.1320212.4520222.6220233.65202402025
Annual Impact Factor Metric
Current (2025):0
Scopus SJR & RankScopus Q3
0.485
#12,218

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
180

180 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
1,113articles/year
0.93% Gold OA•95.33% Original Research

Aims & Scope

Advances in Experimental Medicine and Biology provides a platform for scientific contributions in the main disciplines of the biomedicine and the life sciences. This series publishes thematic volumes on contemporary research in the areas of microbiology, immunology, neurosciences, biochemistry, biomedical engineering, genetics, physiology, and cancer research. Covering emerging topics and techniques in basic and clinical science, it brings together clinicians and researchers from various fields.

Topics Covered (Recognized by AI)
BiologyMedicineChemistryGeneticsBiochemistryInternal MedicinePhysicsEndocrinologyOrganic ChemistryImmunologyPsychologyCell BiologyPathologyNuclear Magnetic Resonance

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF—
Articles / Year391
Total Citations69
2025
IF0
Articles / Year662
Total Citations1,069
2024
IF3.65
Articles / Year636
Total Citations2,751
2023
IF2.622
Articles / Year793
Total Citations3,918
2022
IF2.45
Articles / Year713
Total Citations5,811

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,218Scopus Q3SCImago Profile
Scopus Coverage:1971-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.485

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.76

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,787 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,200
3-Year Documents2,139
Citable Documents125

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q3
Medicine (miscellaneous)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Advances in Experimental Medicine and Biology (abbr: ADV EXP MED BIOL, ISSN: 0065-2598) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer New York in United States since 1967. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.485 (Q3), an H-index of 180.

The journal enforces rigorous peer evaluation with a publication frequency of Irregular, an annual output of approximately 1,113 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,787 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer New York
Publication Language
English
Frequency
Irregular
Founding Year
1967
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER-VERLAG BERLIN, HEIDELBERGER PLATZ 3, BERLIN, GERMANY, D-14197

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 1fe23903-c7a8-4eef-a9bb-1bda41c1d614
Database Updated: 2026-09-28